Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

BRUSSELS, Sept. 30 /- People with Parkinson's disease who used once-daily Neupro® (rotigotine) in the RECOVER trial achieved improvements in quality of life, in addition to previously reported beneficial effects on motor and non-motor symptoms. Data presented this week at the 2nd...

TOPICS:

Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites

September 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Sept. 30 /- A global pharmaceutical company has initiated a prospective trial to evaluate the impact of insulin guidelines developed by the Indian National Consensus group in collaboration with Max Neeman, a leading India-based Contract Research Organization....

TOPICS:

New Study Reveals Collagenase SANTYL® Ointment More Effective Than Hydrogel Dressing for Pressure Ulcer Debridement

September 30, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

FORT WORTH, Texas, Sept. 30 /- Healthpoint today announced that the results of a new study conducted by Catherine T. Milne APRN, MSN, CWOCN, BC-ANP, will be presented on Thursday, September 30, 2010 at 7:15pm (Eastern) at the Healthpoint booth (#110) during the 25th Annual Clinical...

TOPICS:
Advertisement

Disparities 2010: Interview with Rep. Elijah Cummings (D-Md.)

September 30, 2010 10:32 am | by AACR | News | Comments

Listen to Rep. Cummings discuss cancer health disparities with the American Association for Cancer Research.

TOPICS:

Disparities 2010: Interview with Deborah M. Smith, M.D., M.P.H.

September 30, 2010 10:32 am | by AACR | News | Comments

Listen to Dr. Smith as she speaks with the American Association for Cancer Research on the issue of cancer health disparities.

TOPICS:

Genetic parsing of precursor protein gives clues to Alzheimer's disease

September 30, 2010 10:32 am | by Baylor College of Medicine | News | Comments

As researchers try to understand how a particular protein sets the stage for the toxic plaques that wreak havoc on the brains of people with Alzheimer's disease, they face a dilemma. This protein, called the amyloid precursor protein, not only begins the damaging process that results in...

TOPICS:

Older adults can fight frailty through resistance weight training

September 30, 2010 10:31 am | by Baylor College of Medicine | News | Comments

Imagine not being able to stand up because you can't carry your own body weight. To prevent this, incorporate resistance weight training into your routine, said an expert at Baylor College of Medicine . "As we age, we slowly start to lose lean muscle mass, and resistance weight training...

TOPICS:

St. Jude gets OK in Japan for spinal cord system

September 30, 2010 9:45 am | by The Associated Press | News | Comments

Medical device maker St. Jude Medical Inc. said Thursday it received regulatory approval in Japan for its Eon Mini spinal cord stimulation system.The company said the device is the "world's smallest, longest-lasting" rechargeable neurostimulator. The devices are used to manage chronic pain of...

Advertisement

Twins provide clue that genetic epilepsy can originate in the embryo

September 30, 2010 9:33 am | by EurekAlert | News | Comments

(University of Melbourne) An Australian study of identical twins shows that a rare genetic form of epilepsy can be caused by a genetic mutation that occurs in the embryo, and not necessarily passed down from parents.

TOPICS:

Solos Endoscopy, Inc. Announces Results of 2010 Annual Shareholder Meeting

September 30, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

BOSTON, Sept. 30 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce the results of the 2010 annual shareholder meeting held September 28, 2010 near Solos' headquarters in Boston, MA. During Solos' annual shareholder meeting, Robert Segersten, Amanda Segersten and Fred...

TOPICS:

Reportlinker Adds Global Immunoassay Systems Industry

September 30, 2010 8:31 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 30 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Immunoassay Systems Industry http://www.reportlinker.com/p0305127/Global-Immunoassay-Systems-Industry.html This report analyzes the worldwide markets for Immunoassay...

TOPICS:

Generex bumps out Gluskin; Fletcher, Barratt fill CEO, chairman roles

September 30, 2010 7:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Worcester drug discovery firm Generex Biotechnology Corp. has named Mark Fletcher as CEO and interim president, replacing Generex co-founder, CEO, president and chairman Anna Gluskin.

Reportlinker Adds Global Protein Drugs Industry

September 30, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 30 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Protein Drugs Industry http://www.reportlinker.com/p0305169/Global-Protein-Drugs-Industry.html This report analyzes the Global market for Protein Drugs in US$ Million...

TOPICS:

Minnow Medical Names Raymond W. Cohen as Chief Executive Officer

September 30, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

LAGUNA HILLS, Calif., Sept. 30 /- Minnow Medical, Inc., a developer of a novel platform technology employing radiofrequency thermoplasty for the treatment of in-stent restenosis and other peripheral vascular conditions, announced today that veteran medical technology executive Raymond W....

TOPICS:

Meridian gets Canadian approval for molecular test

September 30, 2010 6:45 am | by The Associated Press | News | Comments

Meridian Bioscience Inc. said Thursday it has received Canadian regulatory approval to sell its illumigeneT molecular test for clostridium difficile, which can cause diarrhea and colon inflammation.The company said the approval will help it meet the needs of its clinical laboratory customers....

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading